Warning letter
Natureplex, LLC: warning letter of Aug 18, 2004
FDA warning letter UCM146556 · New Orleans District Office
Key facts
| Reference number | UCM146556 |
|---|---|
| Company | Natureplex, LLC |
| Subject | Current Good Mfg Practice Regulation/Adulterated/Misbranded |
| Issue date | Aug 18, 2004 |
| Posted date | Aug 18, 2004 |
| Issuing office | New Orleans District Office |
| Product type | Unknown |
| CFR sections cited | 211.80(d), 211.101, 211.130, 211.182, 211.188, 349, 211.22(a), 211.25(a), 211.42(c)(10)(iii), 211.67(a), 211.80(a), 211.84(a) and 13 more |
| Country | 3 |
| Inspection city | Olive Branch |
| Inspection ZIP | 38654-4001 |
| Inspection start date | Feb 23, 2004 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: